The €6.1 million project INNO4COV-19 is committed to supporting the commercialization of new products across Europe for combating COVID-19 over the next two years.
Looking for the fast development of products – from medical technologies to surveillance solutions – the project will boost innovation to tackle the new coronavirus, reinforcing Europe’s technological leadership, and invigorating an industrial sector capable of protecting citizens’ safety and well-being.
Officially starting on October 1, the virtual kick-off took place on October 6-7, counting with the support of two European Commission officers.
The mission of INNO4COV-19 is to create a “lab-to-fab” platform and a collaboration resource where companies and reference laboratories will find the tools for developing and implementing innovative technologies – from idea assessment to market exploitation. This work will be carried out as part the European Union Coronavirus initiative and in strong collaboration with all the funded projects where to accelerate the time to market for any promising product.